Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tianjin Pharmaceutical Da Ren Tang Group, previously known as Tianjin Zhongxin Pharmaceutical, announced the release and listing of restricted A-shares under its 2019 Restricted A-Share Incentive Scheme. This move is part of the company’s ongoing efforts to incentivize its workforce and align their interests with shareholders, potentially impacting its stock performance positively.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
